Metraipolis › archive › dc_fd1410c009dc

A clinical decision framework for redox-adapted, EMT-high cancers: From ferroptosis resistance to precision therapeutic stratification — Europe PMC PMID:41903320

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41903320
DOI
10.1016/j.redox.2026.104111
License (as archived)
solo-consultazione
Archived
2026-11-05T03:00:47.976Z
SHA-256 of the archived text
9d0836071ab32ea28545ff5f561570c5b54f647d3472a215c927df91a2e26527
Stable URL of this page
https://metraipolis.com/documento/dc_fd1410c009dc

How to cite

A clinical decision framework for redox-adapted, EMT-high cancers: From ferroptosis resistance to precision therapeutic stratification — Europe PMC PMID:41903320 — Europe PMC (en), https://europepmc.org/article/MED/41903320 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd1410c009dc (Metraipolis archive dc_fd1410c009dc, sha256 9d0836071ab32ea28545ff5f561570c5b54f647d3472a215c927df91a2e26527)
BibTeX
@misc{dcfd1410c009dc,
  title = {A clinical decision framework for redox-adapted, EMT-high cancers: From ferroptosis resistance to precision therapeutic stratification — Europe PMC PMID:41903320},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41903320},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd1410c009dc; sha256 9d0836071ab32ea28545ff5f561570c5b54f647d3472a215c927df91a2e26527},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41903320. Agents can read the archived copy with the MCP tool read_document.